ACUTAAS CHEMICALS Q2: REVENUE UP 42.7% YOY; RAISES FY27 REVENUE GROWTH GUIDANCE TO 30%, EBITDA MARGIN GUIDANCE TO 38–40%

• Revenue Growth: Up 42.7% YoY to ₹436.90 Cr in Q2 FY27 • Pharmaceutical Intermediates: Strong business momentum remained the key driver of revenue growth • Specialty Chemicals: Softer performance partially offset growth in Pharmaceutical Intermediates • South Korea Expansion: Inaugurated new semiconductor chemicals manufacturing facility ahead of schedule • Semiconductor Opportunity: Facility designed to manufacture high-purity chemicals for photoresists, semiconductor packaging, etching and other applications • FY27 Revenue Guidance: Upgraded growth target to approximately 30% from the earlier 25% • EBITDA Margin Guidance: Management raised FY27 EBITDA margin guidance to 38–40% • Order Pipeline: Improved revenue visibility and robust order pipeline support management's upgraded growth expectations • Growth Outlook: Strong Pharmaceutical Intermediates demand and expansion into semiconductor chemicals expected to support future growth

ACUTAAS CHEMICALS LIMITED

← Back to feed